  | | | | | NEW YORK (Reuters) - U.S. stock index futures pointed to a sharply lower open on Monday as a last-minute deal to resolve a budget battle in Washington appeared less likely, increasing the chances of a partial government shutdown. | | |  | | | | | MELBOURNE (Reuters) - OZ Minerals Ltd said on Monday it had not been approached by Glencore Xstrata with any offer, dismissing a British newspaper report that said Glencore was weighing a 750 million pound ($1.2 billion) bid for the Australian copper miner. | | | |  | | | | | NEW YORK (Reuters) - Wall Street banks have had another rough quarter in bond trading thanks to the U.S. Federal Reserve, and it might get worse before it gets better. | | | |  | | | | | MUNICH/FRANKFURT (Reuters) - Weekend news of 15,000 job cuts at Germany's Siemens has put the German engineering group's new chief executive, Joe Kaeser, on a collision course with workers' representatives only two months after he took the helm. | | | |  | | | | | BEIJING (Reuters) - BMW , Hyundai Motor Co and Hyundai's affiliate Kia Motors Corp are recalling a total of 181,492 cars in China, the country's quality watchdog said on Friday. | | | | | | | LONDON (Reuters) - Britain's biggest drugmaker GlaxoSmithKline agreed the 700 million pounds ($1.13 billion) sale of its thrombosis drug brands and a related factory to Aspen Pharmacare , as part of its strategy to focus on growth products. | | | |  | | | | | LONDON (Reuters) - Fixing ailing drugmaker AstraZeneca remains a work in progress for Chief Executive Pascal Soriot, with sales and profits still heading firmly downhill after his first year in the job. | | | |  | | | | | MOSCOW (Reuters) - Oil group Rosneft is to buy the remaining shares in TNK-BP Holding for a fraction of the price it paid BP and a group of oligarchs for their stakes, in a worrying development for minority shareholders in Russian companies. | | | | | | LONDON (Reuters) - Global investors cut allocation to U.S. equities and bonds this month as uncertainty about U.S. monetary and fiscal policies grew, a Reuters poll showed on Monday. | | |  | | | | | MUMBAI (Reuters) - The pharmaceutical industry should support the Chinese government's efforts to curb corruption, French drugmaker Sanofi's Chief Executive Chris Viehbacher said on Monday. | | | |  |  | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | |  | |  | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment